MARKET

BMY

BMY

Bristol-Myers Squibb Co
NYSE
59.70
+0.11
+0.18%
Pre Market: 59.71 +0.01 +0.02% 05:10 10/08 EDT
OPEN
59.45
PREV CLOSE
59.59
HIGH
60.10
LOW
59.01
VOLUME
120
TURNOVER
--
52 WEEK HIGH
67.94
52 WEEK LOW
40.71
MARKET CAP
121.95B
P/E (TTM)
13.15
1D
5D
1M
3M
1Y
5Y
1D
Does Expanded CAMZYOS Approval Change The Bull Case For Bristol Myers Squibb Stock?
Simply Wall St · 10h ago
2 High-Yield Stocks to Buy in October (Hint: Bristol Myers Squibb Is One)
The Motley Fool · 11h ago
Bristol-Myers Squibb: Balanced Segment Growth, The Pullback Is An Opportunity
Seeking Alpha · 11h ago
Tempus AI Doubles Down On Moderna and Merck Cancer Vaccine Infrastructure
Benzinga · 16h ago
Pharma lobby group sues Trump administration over MFN pricing
Seeking Alpha · 19h ago
Bristol-Myers Squibb Is Maintained at Underweight by Morgan Stanley
Dow Jones · 19h ago
Bristol-Myers Squibb Price Target Raised to $41.00/Share From $40.00 by Morgan Stanley
Dow Jones · 19h ago
Morgan Stanley Maintains Underweight on Bristol-Myers Squibb, Raises Price Target to $41
Benzinga · 20h ago
More
About BMY
Bristol-Myers Squibb Company is a global biopharmaceutical company. It is engaged in the discovery, development, and delivery of transformational medicines for patients facing serious diseases in areas: oncology, hematology, immunology, cardiovascular, neuroscience and other areas. Its growth portfolio includes Opdivo (nivolumab), Opdivo Qvantig (nivolumab and hyaluronidase-nvhy), Orencia (abatacept), Yervoy (ipilimumab), Reblozyl (luspatercept-aamt), Breyanzi (lisocabtagene maraleucel), Opdualag (nivolumab and relatlimab-rmbw), Camzyos (mavacamten), Zeposia (ozanimod), Abecma (idecabtagene vicleucel), Sotyktu (deucravacitinib), Krazati (adagrasib), and Cobenfy (xanomeline and trospium chloride). Its other growth products include Augtyro, Onureg, Inrebic, Nulojix, and Empliciti. Its legacy portfolio includes Eliquis (apixaban), Revlimid (lenalidomide), Pomalyst/Imnovid (pomalidomide), Sprycel (dasatinib), and Abraxane (paclitaxel albumin-bound particles for injectable suspension).

Webull offers Bristol-Myers Squibb Co stock information, including NYSE: BMY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BMY stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BMY stock methods without spending real money on the virtual paper trading platform.